Company · CIK 0000892112
SIRNA THERAPEUTICS INC
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13D/ASIRNA THERAPEUTICS INC0000950133-07-000013 · 61.8 KBSEC(opens sec.gov)
- 8-KCurrent report0000950134-06-023620 · 74.3 KBSEC(opens sec.gov)
- 8-KCurrent report0000950149-06-000354 · 14.3 KBSEC(opens sec.gov)
- 4Insider trades0001293941-06-000015 · 5.9 KBSEC(opens sec.gov)
- 4/ASIRNA THERAPEUTICS INC0001239242-06-000002 · 6.6 KBSEC(opens sec.gov)
- 8-KCurrent report0000950134-06-008493 · 42.0 KBSEC(opens sec.gov)
- 4Insider trades0001144204-05-027745 · 7.9 KBSEC(opens sec.gov)
- 8-KCurrent report0001144204-05-027572 · 23.5 KBSEC(opens sec.gov)
- 8-KCurrent report0001144204-05-024300 · 48.4 KBSEC(opens sec.gov)
- SC 13D/ASIRNA THERAPEUTICS INC0001144204-05-022023 · 417.1 KBSEC(opens sec.gov)
Insiders
- CHOWRIRA BHARAT MVP Legal & Chief Patent Couns
- COOK JEREMY CURNOCKDirector
- CREDIT SUISSE AG/10% Owner
- FAMBROUGH DOUGLASDirector
- FRENCH J MICHAELSr. VP, Corporate Development
- GREER R SCOTTDirector
- GUERCIOLINI ROBERTOChief Med Off & Sr. VP of Dev.
- LANGER DENNISDirector
- MRNA FUND II LP10% Owner
- NIEDEL JAMESDirector, 10% Owner
Tickers
No tickers on record.
Addresses
business
185 BERRY STREET SUITE 6504
SAN FRANCISCO, CA, 94107
mailing
185 BERRY STREET SUITE 6504
SAN FRANCISCO, CA, 94107
Former names
- RIBOZYME PHARMACEUTICALS INC2003-03-28
Same industry